METASTATIC CANCER
Clinical trials for METASTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CANCER trials appear
Sign up with your email to follow new studies for METASTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney cancer patients with bone metastases: drug combo trial launches
Disease control Not yet recruitingThis study tests a new drug called zanzalintinib, taken with a bone-strengthening agent, in 20 people whose kidney cancer has spread to the bones and has worsened after prior immunotherapy. The goal is to see if this combination can stop the cancer from growing for at least 12 mo…
Matched conditions: METASTATIC CANCER
Phase: PHASE2 • Sponsor: Kelly Fitzgerald, MD • Aim: Disease control
Last updated May 17, 2026 00:59 UTC
-
DNA-Matched drugs may outperform standard care for advanced cancer
Disease control Not yet recruitingThis study tests whether drugs chosen based on a patient's tumor DNA mutations can delay cancer growth longer than standard treatments. About 280 adults with metastatic or unresectable solid cancers will be randomly assigned to either personalized drugs or usual care. Participant…
Matched conditions: METASTATIC CANCER
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New study tests if tiny probes can slash cancer pain without heavy drugs
Symptom relief Not yet recruitingThis study looks at whether interventional radiology—a minimally invasive technique using needles or catheters—can reduce pain and improve quality of life in people with advanced or metastatic cancer. About 125 adults whose cancer has spread and who are expected to live at least …
Matched conditions: METASTATIC CANCER
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated May 17, 2026 00:59 UTC